Movement Disorders, 2022
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease

Bartl M., Dakna M., Schade S. et al.

Nature Communications, 2022
Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma

Rabold K., Zoodsma M., Grondman I. et al.

Rheumatology, 2022
Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study

Wadström K., Jacobsson L., Mohammad A. et al.

Nature Communications, 2022
Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke

Chen L., Peters J., Prins B. et al.

Cancer Medicine, 2022
Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer

Lindgaard S., Sztupinszki Z., Maag E. et al.

eLife, 2022
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study

Hu Z., van der Ploeg K., Chakraborty S. et al.

Arthritis & Rheumatology, 2022
Cartilage Acidic Protein 1 in Plasma Associates With Prevalent Osteoarthritis and Predicts Future Risk as Well as Progression to Joint Replacements: Results From the UK Biobank Resource

Styrkarsdottir U., Lund S., Thorleifsson G. et al.

Journal of Translational Medicine, 2022
Inflammatory plasma proteins predict short-term mortality in patients with an acute myocardial infarction

Schmitz T., Harmel E., Heier M. et al.

Journal of Crohn's and Colitis, 2022
Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers

Nyström N., Prast-Nielsen S., Correia M. et al.

European Urology, 2022
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder Cancer

Strandgaard T., Lindskrog S., Nordentoft I. et al.

ESC Heart Failure, 2022
Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study

Eidizadeh A., Schnelle M., Leha A. et al.

American Journal of Hypertension, 2022
Renin: Measurements, Correlates, and Associations With Long-Term Adverse Kidney Outcomes

Blum M., Chen J., Surapaneni A. et al.

Communications Medicine, 2022
Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment

Enroth S., Ivansson E., Lindberg J. et al.

Reproductive Sciences, 2022
Early Mid-pregnancy Blood-Based Proteins as Possible Biomarkers of Increased Infant Birth Size in Sex-Stratified Analyses

Lindberger E., Ahlsson F., Junus K. et al.

eJHaem, 2022
Inflammatory biomarkers after an exercise intervention in childhood acute lymphoblastic leukemia survivors

Lähteenmäki Taalas T., Järvelä L., Niinikoski H. et al.

Atherosclerosis Plus, 2022
TACE/ADAM17 substrates associate with ACS (Ep-CAM, HB-EGF) and follow-up MACE (TNFR1 and TNFR2)

Chemaly M., McAllister R., Peace A. et al.

Neurochemistry International, 2022
Plasma protein alterations during human large vessel stroke: A controlled comparison study

Hazelwood H., Frank J., Maglinger B. et al.

International Immunopharmacology, 2022
MAPK activated kinase 2 inhibition shifts the chemokine signature in arthritis synovial fluid mononuclear cells from CXCR3 to CXCR2

Kragstrup T., Sørensen A., Brüner M. et al.

Nature Immunology, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

Dubrot J., Du P., Lane-Reticker S. et al.

Movement Disorders, 2022
Disease Progression, Resilience, and Inflammation Markers During the Coronavirus Disease 2019 Pandemic in Parkinson's Disease

Pauly C., Glaab E., Hansen M. et al.